When a healthy person eats, GLP-1 is released into their bloodstream from the intestines, stimulating insulin secretion from the pancreas while also slowing down the rate at which food moves through the digestive system
It is not a substitute for professional medical advice, diagnosis, or treatment
While these findings offer reassurance in cases of inadvertent exposure to GLP-1 medications during the first trimester of pregnancy, larger trials are needed for more conclusive results
This suggests a new gutbrainimmune axis, where the brains GLP-1 receptor activity suppresses systemic inflammation through sympathetic signaling pathways Whats exciting here is that the anti-inflammatory effects dont seem to be explained by weight loss alone
Suspected adverse reactions to any unlicensed product should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk
Tirzepatide may be recommended for patients who have not seen the desired results with semaglutide or for those dealing with insulin resistance and higher body mass indexes